{"transactions":[{"id":896545,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2026-02-18T21:25:37.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":51,"price":1.1,"value":56.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 51 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":1657,"source":{"system":"sec-edgar","filing":"0001579988-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000157998826000004/ownership.xml","form_type":"4"}},{"id":919266,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T21:14:16.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":69484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date."}],"balance_after":69484,"derivative":{"exercise_price":1.27,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":69484},"source":{"system":"sec-edgar","filing":"0001579988-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000157998826000002/ownership.xml","form_type":"4"}},{"id":1124671,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-06-03T22:58:31.000Z","date":"2025-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":75,"price":3.69,"value":276.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 75 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 75 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":1708,"source":{"system":"sec-edgar","filing":"0001411690-25-000053","document":"wk-form4_1748991505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000053/wk-form4_1748991505.xml","form_type":"4"}},{"id":1199463,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-18T22:45:35.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":17449,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date."}],"balance_after":17449,"derivative":{"exercise_price":3.47,"expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":17449},"source":{"system":"sec-edgar","filing":"0001411690-25-000028","document":"wk-form4_1742337929.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000028/wk-form4_1742337929.xml","form_type":"4"}},{"id":1199462,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-18T22:45:35.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":198,"price":3.47,"value":687.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 198 shares of common stock in connection with shares that vested on March 14, 2025 pursuant to an PSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the PSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 198 shares of common stock in connection with shares that vested on March 14, 2025 pursuant to an PSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the PSU award."}],"balance_after":1783,"source":{"system":"sec-edgar","filing":"0001411690-25-000028","document":"wk-form4_1742337929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000028/wk-form4_1742337929.xml","form_type":"4"}},{"id":1259586,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-19T23:56:56.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":51,"price":5.73,"value":292.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 51 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 51 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 120,428 less shares of common stock (119,934 less shares held directly and 494 less shares held indirectly)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 10, 2024 (As adjusted for the January 2025 Reverse Stock Split)."}],"balance_after":1981,"source":{"system":"sec-edgar","filing":"0001411690-25-000017","document":"wk-form4_1740009410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000017/wk-form4_1740009410.xml","form_type":"4"}},{"id":1489804,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T21:43:39.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":204000,"derivative":{"exercise_price":0.93,"expiration_date":"2034-06-02","underlying":"Common Stock","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001415889-24-015621","document":"form4-06052024_090635.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924015621/form4-06052024_090635.xml","form_type":"4"}},{"id":1489803,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-06-05T21:43:39.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 150 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the \"ESPP\") on June 9, 2023."}],"balance_after":121813,"source":{"system":"sec-edgar","filing":"0001415889-24-015621","document":"form4-06052024_090635.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924015621/form4-06052024_090635.xml","form_type":"4"}},{"id":1595276,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-05T22:46:30.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3073,"price":1.27,"value":3902.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 3,073 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 3,073 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On August 4, 2023, the common stock of Bionano Genomics, Inc. split 1-for-10, resulting in the reporting person's ownership of 730,350 less shares of common stock (725,827 less shares held directly and 4,523 less shares held indirectly)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 89 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 12, 2023."}],"balance_after":77663,"source":{"system":"sec-edgar","filing":"0001415889-24-006809","document":"form4-03052024_100317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924006809/form4-03052024_100317.xml","form_type":"4"}},{"id":1891349,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-16T22:23:46.000Z","date":"2023-05-16","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.6426,"value":9639.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.64160 to $0.643099, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":806474,"source":{"system":"sec-edgar","filing":"0001411690-23-000032","document":"wf-form4_168427581326105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000032/wf-form4_168427581326105.xml","form_type":"4"}},{"id":1891347,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-16T22:18:28.000Z","date":"2023-05-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":50141,"price":0.66,"value":33093.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 50,141 shares of common stock that vested on May 12, 2023 pursuant to an RSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":791474,"source":{"system":"sec-edgar","filing":"0001411690-23-000029","document":"wf-form4_168427549067289.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000029/wf-form4_168427549067289.xml","form_type":"4"}},{"id":2007301,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-18T00:23:47.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":1400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2023 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":1400000,"derivative":{"exercise_price":1.63,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":1400000},"source":{"system":"sec-edgar","filing":"0001209191-23-010921","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123010921/doc4.xml","form_type":"4"}},{"id":2007300,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-18T00:23:47.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,443 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the \"ESPP\") on June 10, 2022 and 1,616 shares acquired under the ESPP on December 10, 2022."}],"balance_after":841615,"source":{"system":"sec-edgar","filing":"0001209191-23-010921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123010921/doc4.xml","form_type":"4"}},{"id":2270171,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-05-17T01:23:46.000Z","date":"2022-05-12","kind":"tax_withholding","acquired":false,"shares":50141,"price":1.41,"value":70698.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 50,141 shares of common stock that vested on May 12, 2022 pursuant to an RSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,804 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the \"ESPP\") on June 10, 2021 and 1,702 shares acquired under the ESPP on December 10, 2021."}],"balance_after":538556,"source":{"system":"sec-edgar","filing":"0001209191-22-029457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919122029457/doc4.xml","form_type":"4"}},{"id":2394247,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-16T02:05:02.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":1400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2022 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":1400000,"derivative":{"exercise_price":2.18,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":1400000},"source":{"system":"sec-edgar","filing":"0001209191-22-010044","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919122010044/doc4.xml","form_type":"4"}},{"id":2490492,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-01T11:00:11.000Z","date":"2021-11-29","kind":"purchase","acquired":true,"shares":150,"price":3.98,"value":597.0,"ownership":{"direct":false,"nature":"Robert Erik Holmlin Traditional IRA"},"balance_after":5025,"source":{"system":"sec-edgar","filing":"0001209191-21-067229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121067229/doc4.xml","form_type":"4"}},{"id":2490491,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-01T11:00:11.000Z","date":"2021-11-29","kind":"purchase","acquired":true,"shares":2675,"price":3.99,"value":10673.25,"ownership":{"direct":false,"nature":"Robert Erik Holmlin Traditional IRA"},"balance_after":4875,"source":{"system":"sec-edgar","filing":"0001209191-21-067229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121067229/doc4.xml","form_type":"4"}},{"id":2490490,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-01T11:00:11.000Z","date":"2021-11-29","kind":"purchase","acquired":true,"shares":2200,"price":3.985,"value":8767.0,"ownership":{"direct":false,"nature":"Robert Erik Holmlin Traditional IRA"},"balance_after":2200,"source":{"system":"sec-edgar","filing":"0001209191-21-067229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121067229/doc4.xml","form_type":"4"}},{"id":2712201,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-14T23:16:14.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."}],"balance_after":585191,"source":{"system":"sec-edgar","filing":"0001209191-21-032934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121032934/doc4.xml","form_type":"4"}},{"id":2712200,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-14T23:16:14.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: 218 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the \"ESPP\") on December 10, 2018, 450 shares acquired under the ESPP on June 10, 2019, 728 shares acquired under the ESPP on December 10, 2019, 1,014 shares acquired under the ESPP on June 10, 2020 and 1,151 shares acquired under the ESPP on December 10, 2020."}],"balance_after":295191,"source":{"system":"sec-edgar","filing":"0001209191-21-032934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121032934/doc4.xml","form_type":"4"}},{"id":2760908,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T22:32:20.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":775000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of April 1, 2021 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":775000,"derivative":{"exercise_price":7.83,"expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":775000},"source":{"system":"sec-edgar","filing":"0001209191-21-024789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121024789/doc4.xml","form_type":"4"}},{"id":3222452,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-06T19:06:38.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of March 1, 2019 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":145000,"derivative":{"exercise_price":4.25,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001209191-20-016870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919120016870/doc4.xml","form_type":"4"}},{"id":3259232,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-21T00:23:39.000Z","date":"2020-02-18","kind":"grant","acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 18, 2020 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":290000,"derivative":{"exercise_price":1.04,"expiration_date":"2030-02-17","underlying":"Common Stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001209191-20-011297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919120011297/doc4.xml","form_type":"4"}},{"id":3798445,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-03T20:28:34.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":256540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on October 1, 2018, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":256540,"derivative":{"exercise_price":7.77,"expiration_date":"2028-09-30","underlying":"Common Stock","underlying_shares":256540},"source":{"system":"sec-edgar","filing":"0001209191-18-053807","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118053807/doc4.xml","form_type":"4"}},{"id":3832713,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock Warrants (right to buy)","published_at":"2018-08-27T22:53:57.000Z","date":"2018-08-23","kind":"purchase","acquired":true,"shares":1630,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Units purchased in the Issuer's Initial Public Offering for $6.125 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"9/21/18 or such earlier date as Roth Capital Partners LLC, as representative of the underwriters in the Company's Initial Public Offering, shall determine."}],"balance_after":1630,"derivative":{"exercise_price":6.125,"expiration_date":"2023-08-21","underlying":"Common Stock","underlying_shares":1630},"source":{"system":"sec-edgar","filing":"0001209191-18-048559","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118048559/doc4.xml","form_type":"4"}},{"id":3832712,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-08-27T22:53:57.000Z","date":"2018-08-23","kind":"purchase","acquired":true,"shares":1630,"price":6.125,"value":9983.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Units purchased in the Issuer's Initial Public Offering for $6.125 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock."}],"balance_after":1630,"source":{"system":"sec-edgar","filing":"0001209191-18-048559","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118048559/doc4.xml","form_type":"4"}}]}